Company / Current Assets
Aurinia Pharmaceuticals Inc. Current Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$492.0M
FY2025
5-year range
$424.8M / $513.3M
FY2021-FY2025
Trend
+10.2%
vs FY2024
Sector context
#116 of 213
Health Care
What the data says
At $492M, Aurinia Pharmaceuticals Inc.'s current assets ranks #116 of 213 in the Health Care sector. Improved from $425M to $492M over the past 2 years.
Based on SEC 10-K filings.
$492M in FY2025 with a 5-year CAGR of +3.2%.
Improved from $425M to $492M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +3.6%
- 5-Year CAGR
- +3.2%
- 10-Year CAGR
- -
Sector benchmark
#116 of 213 in Health CareTop 54% of 213This company $492.0M Sector average $2.5B
▼
-80.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +3.2%, indicating consistent growth.
- In FY2025, current assets increased 10.2% year-over-year.
- Ranks #116 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $492.0M | +10.2% |
| FY2024 | $446.6M | +5.1% |
| FY2023 | $424.8M | -4.0% |
| FY2022 | $442.5M | -13.8% |
| FY2021 | $513.3M | +22.4% |
| FY2020 | $419.4M | +33.1% |
| FY2019 | $315.1M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026